유럽 연합 -
아이슬란드어 -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam accord stungulyf/innrennslislyf, lausn 5 mg/ml
accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 5 mg/ml
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam accord stungulyf/innrennslislyf, lausn 1 mg/ml
accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 1 mg/ml
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
gadovist stungulyf, lausn 1,0 mmól/ml
bayer ab - gadobutrolum inn - stungulyf, lausn - 1,0 mmól/ml
유럽 연합 -
아이슬란드어 -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Æxlishemjandi lyf - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 12,5 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 12,5 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 25 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 25 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 50 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 50 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
strefen munnsogstafla 8,75 mg
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnsogstafla - 8,75 mg
아이슬란드 -
아이슬란드어 -
LYFJASTOFNUN (Icelandic Medicines Agency)
sobril tafla 10 mg
pfizer aps - oxazepamum inn - tafla - 10 mg